Bausch Health Companies (BHC) Enterprise Value (2009 - 2026)
Bausch Health Companies (BHC) reported Enterprise Value of -$335.0 million for Q1 2026, down 56.54% on a YoY basis from -$770.9 million in Q1 2025, and up 14.97% sequentially from -$394.0 million in Q4 2025.
Bausch Health Companies (BHC) Enterprise Value (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Enterprise Value data on file, last reported at -$335.0 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 56.54% year-over-year to -$335.0 million; the trailing twelve-month figure through Mar 2026 stood at -$335.0 million (down 56.54% YoY), and the FY2025 full-year result was -$394.0 million, down 61.48% from the prior year.
- Enterprise Value improved to -$335.0 million in Q1 2026, from -$394.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of $461.0 million in Q3 2022 to a low of -$2.4 billion in Q1 2022.
- A 5-year average of -$196.4 million and a median of -$22.0 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 170.78% in 2022 and tumbled 1009.09% in 2024, its largest moves.
- Tracing BHC's Enterprise Value over 5 years: stood at $361.0 million in 2022, then sank by 106.09% to -$22.0 million in 2023, then plunged by 1009.09% to -$244.0 million in 2024, then slumped by 61.48% to -$394.0 million in 2025, then advanced by 14.97% to -$335.0 million in 2026.
- Business Quant data shows BHC's Enterprise Value at -$335.0 million in Q1 2026, -$394.0 million in Q4 2025, and -$419.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | -335.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -335.00 Mn |
| Dec 31, 2025 | -394.00 Mn |
| Sep 30, 2025 | -419.00 Mn |
| Jun 30, 2025 | -832.00 Mn |
| Mar 31, 2025 | -214.00 Mn |
| Dec 31, 2024 | -244.00 Mn |
| Sep 30, 2024 | 182.00 Mn |
| Jun 30, 2024 | 325.00 Mn |
| Mar 31, 2024 | 186.00 Mn |
| Dec 31, 2023 | -22.00 Mn |
| Sep 30, 2023 | 165.00 Mn |
| Jun 30, 2023 | 346.00 Mn |
| Mar 31, 2023 | 414.00 Mn |
| Dec 31, 2022 | 361.00 Mn |
| Sep 30, 2022 | 461.00 Mn |
| Jun 30, 2022 | -933.00 Mn |
| Mar 31, 2022 | -2.39 Bn |
| Dec 31, 2021 | -510.00 Mn |
| Sep 30, 2021 | -1.84 Bn |
| Jun 30, 2021 | -1.78 Bn |